MARCELLE HOLT: Open Payments
NPI 1871154922 · PONTIAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 36 payments from 15 companies in 2025. Trend: 2023 $627 · 2024 $1,139 · 2025 $820
Food & beverage: $805Education: $15
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $150 |
| Novo Nordisk Inc | 1 | $118 |
| Calliditas Therapeutics US Inc. | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $91 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| Aurinia Pharma U.S., Inc. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Travere Therapeutics, Inc. | 1 | $21 |
Products named: IBSRELA, Wegovy, TARPEYO, ULTOMIRIS, Vanrafia, LUPKYNIS, JARDIANCE, FUROSCIX.
Industry payments across MI — which companies pay providers there.
